268 related articles for article (PubMed ID: 17517880)
1. Clostridium difficile toxins A and B directly stimulate human mast cells.
Meyer GK; Neetz A; Brandes G; Tsikas D; Butterfield JH; Just I; Gerhard R
Infect Immun; 2007 Aug; 75(8):3868-76. PubMed ID: 17517880
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca²⁺ and GTPγS.
Balletta A; Lorenz D; Rummel A; Gerhard R; Bigalke H; Wegner F
Toxicology; 2015 Feb; 328():48-56. PubMed ID: 25497110
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of interleukin-16 in human mast cells HMC-1 by Clostridium difficile toxins A and B.
Gerhard R; Queisser S; Tatge H; Meyer G; Dittrich-Breiholz O; Kracht M; Feng H; Just I
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):285-95. PubMed ID: 21267712
[TBL] [Abstract][Full Text] [Related]
4. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
5. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.
Warny M; Keates AC; Keates S; Castagliuolo I; Zacks JK; Aboudola S; Qamar A; Pothoulakis C; LaMont JT; Kelly CP
J Clin Invest; 2000 Apr; 105(8):1147-56. PubMed ID: 10772660
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins.
Nusrat A; von Eichel-Streiber C; Turner JR; Verkade P; Madara JL; Parkos CA
Infect Immun; 2001 Mar; 69(3):1329-36. PubMed ID: 11179295
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile toxins: mechanism of action and role in disease.
Voth DE; Ballard JD
Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
[TBL] [Abstract][Full Text] [Related]
9. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells.
Tsai CC; Kuo TY; Hong ZW; Yeh YC; Shih KS; Du SY; Fu HW
Virulence; 2015; 6(8):755-65. PubMed ID: 26375619
[TBL] [Abstract][Full Text] [Related]
11. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
12. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
14. Enteric glial cells are susceptible to Clostridium difficile toxin B.
Fettucciari K; Ponsini P; Gioè D; Macchioni L; Palumbo C; Antonelli E; Coaccioli S; Villanacci V; Corazzi L; Marconi P; Bassotti G
Cell Mol Life Sci; 2017 Apr; 74(8):1527-1551. PubMed ID: 27891552
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
16. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
17. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
Just I; Hofmann F; Genth H; Gerhard R
Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
[TBL] [Abstract][Full Text] [Related]
18.
Schweitzer T; Genth H; Pich A
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077344
[No Abstract] [Full Text] [Related]
19. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
20. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
Frädrich C; Beer LA; Gerhard R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
